How common is AKI in cancer patients
The answer depends on the sub-population of patients with a particular malignancy, as well as the clinical setting, for example, intensive care unit (ICU) versus general inpatient service versus outpatient. Four main points may be deduced from major studies:
- 1. The incidence of AKI among hospitalized patients with malignancy is higher than that of patients without cancer
- 2. Acutely ill patients with cancer admitted to the ICU have an even higher risk of AKI
- 3. Some cancers are associated with a higher risk of AKI than others:
- a. Kidney
- b. Gall bladder
- c. Liver
- d. Myeloma
- e. Pancreas
- 4. Treatment with a hematopoetic stem cell transplant (HSCT), especially myeloablative allogenic HSCT, further raises the risk of AKI associated with malignancies
